InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
Amy McBride Wendell
11 Aug 2026
Director
Sold after exercise
13,353
$48.42
$646.59K
Marc A Began
10 Aug 2026
EVP & General Counsel
Sold after exercise
67,500
$47.35
$3.20M
Amy McBride Wendell
8 May 2026
Director
Sold after exercise
1,647
$42.60
$70.16K
Lindsey Marie Hartley
7 May 2026
CFO
Sold after exercise
573
$43.67
$25.02K
Lindsey Marie Hartley
7 May 2026
CFO
Sold after exercise
478
$43.67
$20.87K
Kathy Johnson Weiler
7 May 2026
Director
Sold after exercise
16,344
$44.09
$720.62K
John Johnson
7 May 2026
Director
Sold after exercise
11,050
$43.26
$477.97K
Erick Wayne DeVinney
16 Mar 2026
Chief Innovation Officer
Sold after exercise
5,221
$32.84
$171.46K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
6,580
$29.55
$194.44K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
21,825
$29.55
$644.86K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
18,248
$29.55
$539.17K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
18,248
$29.31
$534.89K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
20,436
$29.31
$599.02K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
5,000
$29.31
$146.56K
Lindsey Marie Hartley
15 Dec 2025
CFO
Sold after exercise
14,812
$29.86
$442.29K
John Johnson
9 Dec 2025
Director
Sold after exercise
13,141
$29.98
$393.99K
John Johnson
9 Dec 2025
Director
Sold after exercise
8,545
$29.98
$256.20K
Joseph A. Tyndall
9 Dec 2025
Director
Sold after exercise
10,860
$30.98
$336.41K
Joseph A. Tyndall
9 Dec 2025
Director
Sold after exercise
14,248
$30.98
$441.36K
Lindsey Marie Hartley
8 Dec 2025
CFO
Sold after exercise
2,854
$31.56
$90.07K
Lindsey Marie Hartley
8 Dec 2025
CFO
Sold after exercise
11,533
$31.56
$363.94K
John Johnson
8 Dec 2025
Director
Sold after exercise
11,891
$31.22
$371.27K
John Johnson
8 Dec 2025
Director
Sold after exercise
11,802
$31.26
$368.93K
William P. Mr. Burke
11 Nov 2025
Director
Sold after exercise
3,591
$24.02
$86.25K
William P. Mr. Burke
10 Nov 2025
Director
Sold after exercise
19,227
$24.01
$461.64K
William P. Mr. Burke
6 Nov 2025
Director
Sold after exercise
5,347
$24.01
$128.37K
William P. Mr. Burke
5 Nov 2025
Director
Sold after exercise
11,431
$24.05
$274.89K
William P. Mr. Burke
30 Oct 2025
Director
Sold after exercise
18,248
$23.00
$419.70K
William P. Mr. Burke
29 Oct 2025
Director
Sold after exercise
19,799
$22.00
$435.58K
William P. Mr. Burke
29 Oct 2025
Director
Sold after exercise
20,436
$19.15
$391.44K
Joseph A. Tyndall
10 Jun 2025
Director
Sold after exercise
26,931
$10.72
$288.70K
Joseph A. Tyndall
22 May 2025
Director
Sold after exercise
7,212
$11.20
$80.77K
Joseph A. Tyndall
22 May 2025
Director
Sold after exercise
12,850
$11.20
$143.92K
Angelo Scopelianos
21 Mar 2024
Chief R&D Officer
Sold after exercise
610
$7.68
$4.68K
Angelo Scopelianos
21 Mar 2024
Chief R&D Officer
Sold after exercise
1,020
$7.68
$7.83K
Angelo Scopelianos
21 Mar 2024
Chief R&D Officer
Sold after exercise
5,251
$7.68
$40.33K
Gregory Gene Freitag
1 Jun 2023
Director
Sold after exercise
29,480
$8.74
$257.66K
Gregory Gene Freitag
1 Jun 2023
Director
Sold after exercise
12,500
$8.65
$108.13K
Peter J Mariani
1 Feb 2023
EVP & Chief Financial Officer
Sold after exercise
14,550
$9.36
$136.19K
Peter J Mariani
31 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
14,320
$9.55
$136.76K
Peter J Mariani
30 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
14,111
$9.69
$136.74K
Peter J Mariani
27 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,940
$10.16
$212.75K
Peter J Mariani
26 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,939
$9.90
$207.30K
Peter J Mariani
25 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,939
$10.23
$214.21K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
1,745
$12.41
$21.66K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
12,854
$12.41
$159.52K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
1,084
$12.41
$13.45K
Peter J Mariani
30 Oct 2020
Chief Financial Officer
Sold after exercise
60,000
$12.41
$744.72K
Show all 250 transactions →

What was left out

Form 4 filings counted 472
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 48
Sales at will 93
Transactions with no price 0
Shares from compensation/vesting 5,060,938
Sales filed before the plan box existed 57
History held since 24 Sep 2007